Unlocking Glioblastoma Vulnerabilities with CRISPR-Based Genetic Screening
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25115702 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yitong Fang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Glioblastoma, CRISPR-Cas Systems, Brain Neoplasms, Genetic Testing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Shenzhen Fundamental Research Program.
Abstract (Originalsprache)
Glioblastoma (GBM) is the most common malignant brain tumor in adults. Despite advancements in treatment, the prognosis for patients with GBM remains poor due to its aggressive nature and resistance to therapy. CRISPR-based genetic screening has emerged as a powerful tool for identifying genes crucial for tumor progression and treatment resistance, offering promising targets for tumor therapy. In this review, we provide an overview of the recent advancements in CRISPR-based genetic screening approaches and their applications in GBM. We highlight how these approaches have been used to uncover the genetic determinants of GBM progression and responsiveness to various therapies. Furthermore, we discuss the ongoing challenges and future directions of CRISPR-based screening methods in advancing GBM research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.
- Key University Laboratory of Metabolism and Health of Guangdong, Southern University of Science and Technology, Shenzhen 518055, China.
ORCID-Profile: Ruilin Tian
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Fundamental Research Program
- Shenzhen Medical Research Fund
- National Training Program of Undergraduate Innovation and Entrepreneurship
- Lingang Laboratory
Zitieren
APA
Fang, Y., Li, X., & Tian, R. (2024). Unlocking Glioblastoma Vulnerabilities with CRISPR-Based Genetic Screening. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115702
Vancouver
Fang Y, Li X, Tian R. Unlocking Glioblastoma Vulnerabilities with CRISPR-Based Genetic Screening. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115702
BibTeX
@article{Fang2024,
author = {Fang, Yitong and Li, Xing and Tian, Ruilin},
title = {Unlocking Glioblastoma Vulnerabilities with CRISPR-Based Genetic Screening},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25115702}
}
EUVIMED